Subscribe to the Pharma Lab Newsletter
CARBOGEN AMCIS Shanghai site achieves successful outcome in unannounced NMPA GMP inspection
CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company, today announces its Shanghai facility has successfully completed an unannounced...
Inhibrx provides clinical update on ozekibart in late line colorectal cancer
Inhibrx Biosciences, a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, has released updated interim data from its phase 1/2 study evaluating...
BioLife Solutions wins Interphex 2026 biotech innovation award for CellSeal CryoCase
BioLife Solutions, a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, has received the Interphex...
US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants
The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5 million) in five R&D projects...
Positive phase 1 data for RAG-17 in amyotrophic lateral sclerosis patients with mutations in the superoxide dismutase 1 gene
Ractigen Therapeutics, a clinical-stage biopharmaceutical company focused on developing next-generation RNA-based medicines, has announced positive preliminary data from the single ascending dose (SAD) phase...
New non-compromise early-phase progression accelerator launched
CARBOGEN AMCIS introduces Sprint for early-phase development, a new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour.
Sprint has been designed to...
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers
Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line, designed to offer broader access to optimised workflows for PCR applications such as sequencing,...
PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities
PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...
© 2026 Pharma Press Publishing.